Effect of trikatu pretreatment on the pharmacokinetics of pefloxacin administered orally in mountain Gaddi goats

Journal of Veterinary Science

Volumn 9, Issue 1, 2008, Pages 25-29

  Dama, Madhukar S ^a   Varshneya, C ^a   Dardi, M S ^b   Katoch, V C ^c  

^a Chaudhary Sarwan Kumar Himachal Pradesh Agricultural University   (India)

^b KRISHI VIGYAN KENDRA   (India)

^c CSK HIMACHAL PRADESH AGRICULTURAL UNIVERSITY   (India)

Author keywords

Goats; Oral administration; Pefloxacin; Pharmacokinetics; Trikatu

Indexed keywords

ANIMALIA; CAPRA HIRCUS;

EID: 45749133040     PISSN: 1229845X     EISSN: None     Source Type: Journal    
DOI: 10.4142/jvs.2008.9.1.25     Document Type: Article

References (15)

1. Abd El-Aty AM, Goudah A. Some pharmacokinetic parameters of pefloxacin in lactating goats. Vet Res Commun 2002, 26, 553-561.
2. Annamalai AR, Manavalan R. Effects of Trikatu and its individual components and piperine on gastrointestinal tract: Trikatu - A bioavailability enhancer. Indian Drugs 1989, 27, 595-604.
3. Atal CK. A breakthrough in drug bioavailability- a clue from age old wisdom of Ayurveda. Indian Drug Manuf Asso Bull 1979, 10, 483-484.
4. Bennett JV, Brodie JL, Benner EJ, Kirby WM. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol 1966, 14, 170-177.
5. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. pp.45-109, Marcel-Dekker, New York, 1982.
6. Lala LG, D'Mello PM, Naik SR. Pharmacokinetic and pharmacodynamic studies on interaction of "Trikatu" with diclofenac sodium. J Ethnopharmacol 2004, 91, 277-280.
7. Singh M, Varshneya C, Telang RS, Srivastava AK. Alteration of pharmacokinetics of oxytetracycline following oral administration of Piper longum in hens. J Vet Sci 2005, 6, 197-200.
8. Malik JK, Rao GS, Ramesh S, Muruganandan S, Tripathi HC, Shukla DC. Pharmacokinetics of pefloxacin in goats after intravenous and oral administration. Vet Res Commun 2002, 26, 141-149.
9. Mathur P, Valpandium T, Sengupta S, Gupta SK. Effect of piperine on analgesic activity of Nimesulide: a possible pharmacokinetic interaction. Indian J Pharm 1998, 30, 204.
10. Montay G, Goueffon Y, Roquet F. Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, mon keys, and humans. Antimicrob Agents Chemother 1984, 25, 463-472.
11. Notari RE. Biopharmaceutics and clinical pharmacokinetics: an introduction. 4th ed. pp.221-270, Marcel-Dekker, New York, 1987.
12. 450 2B1. J Ethnopharmacol 1997, 58, 165-173.
13. Sharma AK, Khosla R, Kela AK, Mehta VL. Fluoroquinolones: Antimicrobial agents of the 90's. Indian J Pharm 1994, 26, 249-261.
14. Snedecor GW, Cochran WG. Statistical Methods. 6th ed. pp.59-65, Iowa State University Press, Ames, 1967.
15. Srivastava AK, Dumka VK, Deol SS. Disposition kinetics and urinary excretion of pefloxacin after intravenous injection in crossbred calves. Vet Res Commun 2000, 24, 189-196.